OVB
- 产品代码
- OVB
- 器械名称
- Hydrogel Spacer
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 892.5725
- FDA 专业组
- Radiology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 7 件
FDA 分类定义
The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patients body over time.
该代码近三年的 510(k)(1 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 |
|---|---|---|---|
| K260119 | 2026-02-10 | Boston Scientific Corporation | SpaceOAR Vue System (SV-2101) 摘要 |
FDA 官方分类页: OVB
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。